Revenue: $1,102,030,000; YoY growth 12.95%; QoQ growth 9.58%
Gross Profit: Not disclosed in the QQ2 2025 results package available here
Operating Income: $479,390,000; Margin 43.50%
Operating Income YoY: +10.63%; QoQ: +12.24%
EBITDA: $581,402,000; EBITDA Margin: 52.76%
Net Income: $284,168,000; Net Margin: 25.78%
EPS (Diluted): $3.98; EPS (Basic): $4.03; YoY EPS growth: ~12.26%; QoQ: ~16.47%
Free Cash Flow: $1,087,611,000; Free Cash Flow per Share: $15.42; FCF Margin vs Revenue: ~98.8%
Cash from Operations: $1,140,247,000; Cash at End of Period: $5,531,358,000; Cash at Beginning: $4,383,423,000
Working Capital Influence on Cash Flow: Accounts Receivable change of −$740,361,000; Accounts Payables change of $1,071,400,000; Other Working Capital: not material; Other Non-Cash Items: $753,467,000
Balance Sheet Health: Total Assets $20,435,226,000; Cash & Equivalents $2,192,849,000; Total Debt $6,478,700,000; Net Debt $4,285,851,000; Long-Term Debt $5,869,083,000; Goodwill $6,334,018,000; Intangible Assets $2,372,305,000; Equity $3,928,573,000; Current Ratio 1.12; Quick Ratio 1.12; Cash Ratio 0.23
Valuation Signals (USD): Price/Earnings 18.54x; EV/EBITDA 43.62x; Price to Sales 19.12x; Price to Free Cash Flow 19.38x; Price to Book 5.36x; Enterprise Value Multiple 43.62x vs peer range observed around 16.96x–99.37x across listed comparables